Effects of MACC1 siRNA on biological behaviors of HeLa

Archives of Gynecology and Obstetrics

Volumn 289, Issue 6, 2014, Pages 1271-1280

  Chai, Hongxia ^a   Yang, Yongxiu ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

Cervical cancer; HeLa cell; Metastasis associated in colon cancer 1; Small interfering RNA

Indexed keywords

METASTASIS ASSOCIATED IN COLON CANCER 1 PROTEIN; SMALL INTERFERING RNA; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER GROWTH; CELL CYCLE PROGRESSION; CELL FUNCTION; CELL MIGRATION; CELL MIGRATION ASSAY; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSKELETAL STAINING; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HELA CELL LINE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MITOSIS; MTT ASSAY; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; STAINING; TRANSWELL MIGRATION; UTERINE CERVIX CANCER; WESTERN BLOTTING;

ADULT; AGED; APOPTOSIS; CELL CYCLE; CELL MOVEMENT; CELL PROLIFERATION; CYTOSKELETON; DISEASE PROGRESSION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; HELA CELLS; HUMANS; MICROSCOPY, CONFOCAL; MIDDLE AGED; MITOSIS; NEOPLASM INVASIVENESS; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS; TRANSFECTION; UTERINE CERVICAL NEOPLASMS;

EID: 84905101652     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-013-3126-z     Document Type: Article

References (20)

1. WHO, Department of Reproductive Health WHO, Department of Chronic Diseases Health Promotion (2006) Comprehensive cervical cancer control: a guide to essential practice. WHO
2. Ferlay J, Shin HR, Bray F (2011) GLOBOCAN 2008: cancer incidence and mortality Worldwide: IARC CancerBase No. 10 (database on the Internet). International agency for research on cancer, Lyon
3. Li J, Jia H, Xie L et al (2009) Correlation of inhibitor of differentiation 1 expression to tumor progression, poor differentiation and aggressive behaviors in cervical carcinoma. Gynecol Oncol 114:89-93
4. Burd EM (2003) Human papillomavirus and cervical cancer. Clin Microbiol Rev 16:1-17
5. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69-90
6. Stein U, Smith J, Walther W, Arlt F (2009) MACC1 controls Met: what a difference an Sp1 site makes. Cell Cycle 8:2467-2469
7. Arlt F, Stein U (2009) Colon cancer metastasis: MACC1 and Met as metastatic pacemakers. Int J Biochem Cell Biol 41:2356-2359
8. Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R et al (2011) Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet 36:40-45
9. Stein U, Walther W, Arlt F, Schwabe H, Smith J, Fichtner I et al (2008) MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nat Med 15:59-67
10. Armes JE, Trute L, White D et al (1999) Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers a population-based study. Cancer Res 59:2011-2017 (Pubitemid 29186179)
11. Bouras T, Southey MC, Venter DJ (2001) Overexpression of the steroid receptor coactivator AIB1 in breast cancer correlates with the absence of estrogen and progesterone receptors and positivity for p53 and HER2/neu. Cancer Res 61:903-907 (Pubitemid 32174400)
12. Birchmeier C, Birchmeier W, Gherardi E, Woude GFV (2003) Met, metastasis, motility and more. Nat Rev Mol Cell Biol 4:915-925 (Pubitemid 37493640)
13. Stella MC, Trusolino L, Pennacchietti S, Comoglio PM (2005) Negative feedback regulation of Met-dependent invasive growth by Notch. Mol Cell Biol 25:3982-3996 (Pubitemid 40617648)
14. Bottaro DP, Rubin JS, Faletto DL, Chan AM, Kmiecik TE, Woude GV, Aaronson SA (1991) Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science (New York, NY) 51:802
15. Blumenschein GR, Mills GB, Gonzalez-Angulo AM (2012) Targeting the hepatocyte growth factor - cMET axis in cancer therapy. J Clin Oncol 30:287-3296
16. Toschi L, Jänne PA (2008) Single-agent and combination therapeutic strategies to inhibit hepatocyte growth factor/MET signaling in cancer. Clin Cancer Res 14:941-5946
17. Kokoszyńska K, Kryński J, Rychlewski L, Wyrwicz LS (2009) Unexpected domain composition of MACC1 links MET signaling and apoptosis. Acta Biochim Pol 56:317-323
18. Boardman LA (2009) Overexpression of MACC1 leads to downstream activation of HGF/MET and potentiates metastasis and recurrence of colorectal cancer. Genome Med 1:36
19. Yu JY, DeRuiter SL, Turner DL (2002) RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc Natl Acad Sci 99:6047-6052 (Pubitemid 34493262)
20. Matsumura A, Kubota T, Taiyoh H, Fujiwara H, Okamoto K, Ichikawa D (2013) HGF regulates VEGF expression via the c-Met receptor downstream pathways, PI3K/Akt, MAPK and STAT3, in CT26 murine cells. Int J Oncol 42:535-542